Armod
$ 94.58 – $ 354.66Price range: $ 94.58 through $ 354.66
Artane
$ 229.49 – $ 552.16Price range: $ 229.49 through $ 552.16
Aromasin
$ 237.83 – $ 2 ,228.10Price range: $ 237.83 through $ 2 ,228.10
Aromasin (exemestane) is an oral medication primarily used in the treatment of breast cancer. It belongs to a class of drugs known as aromatase inhibitors. Aromasin works by reducing the amount of estrogen produced in the body, which can slow the growth of certain types of breast cancer. It is typically prescribed for postmenopausal women with hormone receptor-positive early breast cancer after tamoxifen therapy, or for advanced breast cancer that has progressed after anti-estrogen therapy. This medication plays a crucial role in managing specific forms of breast cancer.
Active ingredient: Exemestane
SKU:
Aromasin
Category: Cancer
Delivery: 5–21 business days (depending on the shipping method selected)
Save an extra 10% with the discount code: EXTRA10
Each dosage option has its own packaging variants.
Description
Aromasin mechanism of action and clinical application in oncology therapy
For countless women across Australia, navigating the complexities of breast cancer treatment is a profound journey that demands effective, reliable, and accessible solutions. Among the critical advancements in endocrine therapy for postmenopausal hormone receptor-positive breast cancer, Aromasin stands as a cornerstone. This potent medication, with its targeted action against estrogen production, offers a significant pathway to improved outcomes and enhanced quality of life. Understanding its mechanism, benefits, and how it fits into a comprehensive treatment plan is essential for anyone considering this vital therapeutic agent.
Here at our online pharmacy, we are committed to empowering Australian women with the knowledge and resources they need to make informed decisions about their health. We proudly offer Aromasin, making it accessible across the country – from the vibrant urban centres of Sydney and Melbourne to regional communities – with unparalleled convenience. Our aim is to provide a seamless and discreet experience, ensuring that essential medications are within reach for those who need them, without the typical barriers.
What is Aromasin (Exemestane)?
Aromasin, known by its active pharmaceutical ingredient exemestane, is a highly effective medication primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. Classified as a steroidal aromatase inhibitor, Aromasin plays a crucial role in reducing the body’s estrogen levels, thereby hindering the growth of certain types of breast cancer cells that depend on estrogen for their proliferation. This medication represents a significant therapeutic advancement, offering a targeted approach to combating a prevalent form of cancer affecting women across Australia and globally.
The development of exemestane marked a pivotal moment in oncology, providing an alternative and often superior option to earlier endocrine therapies. Its unique mechanism of action sets it apart from non-steroidal aromatase inhibitors and selective estrogen receptor modulators like tamoxifen. By offering a distinct pathway for estrogen suppression, Aromasin can be a crucial component in both early-stage and advanced breast cancer management strategies, designed to improve patient outcomes and quality of life. For women in Australia seeking reliable access to this important medication, understanding its fundamental properties is the first step towards informed treatment decisions.
Approved Indications for Aromasin
Aromasin is approved for specific therapeutic uses that address the unique hormonal environment of postmenopausal women dealing with hormone receptor-positive breast cancer. Its efficacy and safety have been rigorously tested and established for these key indications:
-
Adjuvant Treatment of Early Breast Cancer: Aromasin is indicated for the adjuvant treatment of postmenopausal women with estrogen receptor-positive early breast cancer who have completed 2 to 3 years of tamoxifen therapy and are switched to exemestane for a total of 5 consecutive years of adjuvant endocrine therapy. This sequential approach aims to build upon the initial benefits of tamoxifen, providing extended hormonal suppression and further reducing the risk of cancer recurrence. This indication is critical for thousands of women in Australia who seek to minimise the chances of their cancer returning after initial treatment.
-
Treatment of Advanced Breast Cancer: Aromasin is also indicated for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following anti-estrogen therapy. In this setting, where the cancer may have become resistant to other hormonal treatments, Aromasin offers a valuable second-line or subsequent-line option. By effectively shutting down estrogen production, it can help control disease progression, alleviate symptoms, and potentially extend the lives of women facing advanced stages of the disease. This provides hope and a tangible treatment pathway for patients throughout Australia, offering continued therapeutic options when initial treatments have run their course.
These specific indications underscore Aromasin’s targeted utility, focusing exclusively on scenarios where estrogen-dependent cancer growth is a primary concern in postmenopausal women. Its role is precisely defined to maximise therapeutic benefit while ensuring patient safety within a regulated medical framework.
How Aromasin Works: The Science Behind Its Efficacy
The remarkable effectiveness of Aromasin stems from its precise and powerful mechanism of action as a steroidal aromatase inactivator. To understand how Aromasin works, it’s essential to grasp the role of the aromatase enzyme in the body, particularly in postmenopausal women.
In premenopausal women, the ovaries are the primary source of estrogen. However, after menopause, the ovaries cease to produce significant amounts of estrogen. Instead, the main source of estrogen in postmenopausal women becomes the conversion of androgens (male hormones, primarily androstenedione) into estrogens (estrone and estradiol) in peripheral tissues, such as fat, muscle, and liver, as well as in breast cancer tissue itself. This crucial conversion process is facilitated by an enzyme called aromatase.
Aromasin, or exemestane, works by irreversibly binding to the active site of the aromatase enzyme. This “suicide inhibition” means that once Aromasin binds to the enzyme, it permanently deactivates it, preventing it from converting androgens into estrogens. Unlike some other aromatase inhibitors that might reversibly bind and allow the enzyme to become active again, Aromasin’s irreversible action leads to a sustained and profound reduction in estrogen levels throughout the body. This reduction is significant because many breast cancers are “hormone receptor-positive,” meaning their growth is stimulated by estrogen.
By effectively cutting off the supply of estrogen to these cancer cells, Aromasin starves them of the fuel they need to grow and multiply. This leads to a deceleration or cessation of tumor growth, a reduction in tumor size, and a decreased risk of cancer recurrence. The specific steroidal structure of exemestane mimics natural substrates of the aromatase enzyme, which allows it to bind effectively and irreversibly in a highly targeted manner. This scientific precision is why Aromasin is such a valuable treatment option for postmenopausal women with hormone receptor-positive breast cancer, offering a powerful tool in their fight against the disease.
Dosage and Administration of Aromasin
The proper dosage and administration of Aromasin are crucial for maximising its therapeutic benefits and ensuring patient safety. While specific medical guidance is always paramount, the generally accepted regimen for Aromasin is straightforward and designed for convenience.
-
Standard Dosage: The recommended dose of Aromasin (exemestane) is one 25 mg tablet taken orally once daily. This consistent daily intake ensures a steady suppression of aromatase activity and, consequently, estrogen levels.
-
Timing of Administration: It is generally recommended to take Aromasin after a meal. Taking the medication with food, especially a meal containing some fat, can enhance its absorption and bioavailability, ensuring that the body effectively utilises the active ingredient. Establishing a routine, such as taking it after breakfast or dinner, can help with adherence to the daily regimen.
-
Duration of Treatment: The duration of Aromasin treatment varies depending on the specific indication. For adjuvant treatment of early breast cancer, it is typically taken for 2-3 years after tamoxifen, completing a total of 5 years of endocrine therapy. For advanced breast cancer, treatment continues until disease progression or unacceptable toxicity. Adherence to the prescribed duration is vital for achieving the intended long-term benefits and preventing recurrence or progression of the disease.
-
Missed Dose: If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next scheduled dose. In such cases, the missed dose should be skipped, and the regular dosing schedule resumed. It is important not to take a double dose to compensate for a missed one, as this does not improve efficacy and may increase the risk of side effects.
While the administration appears simple, the underlying therapeutic journey requires commitment. For women across Australia, incorporating this daily routine into their lives becomes a key part of their treatment strategy. The availability of Aromasin through our online pharmacy facilitates this process, ensuring that the medication is readily accessible when needed.
Potential Benefits of Aromasin in Breast Cancer Management
The strategic inclusion of Aromasin in the treatment landscape for postmenopausal hormone receptor-positive breast cancer offers a range of significant benefits that contribute to improved patient outcomes and quality of life. These advantages underscore why it remains a critical therapeutic option for women across Australia:
-
Improved Disease-Free Survival (DFS): For women with early breast cancer, switching to Aromasin after an initial period of tamoxifen has been shown to significantly improve disease-free survival. This means a longer period without recurrence of the cancer, offering substantial peace of mind and better long-term prognosis.
-
Reduced Risk of Recurrence: By effectively and persistently lowering estrogen levels, Aromasin reduces the hormonal stimulation that can lead to the regrowth of estrogen-sensitive cancer cells. This translates to a decreased risk of both local and distant recurrence, including metastases to other parts of the body.
-
Extended Time to Progression in Advanced Settings: In postmenopausal women with advanced breast cancer whose disease has progressed after previous anti-estrogen therapy, Aromasin can extend the time to disease progression. This means a longer period where the cancer remains stable or shrinks, providing valuable time and improving the quality of life for patients facing more advanced stages of the disease.
-
Prevention of Contralateral Breast Cancer: Some studies suggest that aromatase inhibitors, including Aromasin, may also help reduce the risk of developing new cancer in the opposite breast (contralateral breast cancer), further enhancing its protective benefits.
-
Distinct Mechanism of Action: As a steroidal aromatase inactivator, Aromasin offers a unique mechanism compared to non-steroidal aromatase inhibitors. This distinct action can be beneficial for patients who may not tolerate or respond optimally to other types of aromatase inhibitors, providing an alternative therapeutic pathway.
These comprehensive benefits highlight Aromasin as a potent and well-tolerated option for appropriate patients, contributing to more effective breast cancer management strategies and ultimately, better health outcomes for women in Australia.
Aromasin (Exemestane) Detailed Characteristics
To provide a clear and concise overview of Aromasin, here is a detailed table summarising its key characteristics. This information is designed to help our customers in Australia understand the fundamental properties of this important medication.
| Characteristic | Description |
|---|---|
| Active Ingredient | Exemestane |
| Drug Class | Steroidal Aromatase Inhibitor (Type 1, Irreversible) |
| Formulation | Oral tablets |
| Strength | 25 mg per tablet |
| Mechanism of Action | Irreversibly binds to and inactivates the aromatase enzyme, blocking the conversion of androgens to estrogens in peripheral tissues, leading to a significant reduction in circulating estrogen levels. |
| Primary Indications | Adjuvant treatment of postmenopausal women with estrogen receptor-positive early breast cancer after 2-3 years of tamoxifen. Treatment of advanced breast cancer in postmenopausal women whose disease has progressed after anti-estrogen therapy. |
| Typical Dosage | 25 mg once daily |
| Administration | Taken orally after a meal to enhance absorption. |
| Metabolism | Primarily hepatic, via CYP3A4 and aldoketo reductase. |
| Elimination | Mainly via urine and faeces as metabolites. |
| Storage | Store at room temperature (typically 20°C to 25°C), away from moisture, heat, and direct light. Keep in original packaging. |
| Availability in Australia | Widely available for those who need it, including through our online platform without a prescription. |
| Target Population | Postmenopausal women only. |
Important Safety Information and Potential Side Effects
While Aromasin is a highly effective medication, it is important for users to be aware of potential side effects and safety considerations. Understanding these can help individuals manage their treatment journey more effectively. Please note that this information is general; individual responses to medication can vary.
Common Side Effects: Many women taking Aromasin may experience side effects, most of which are mild to moderate and manageable. These can include:
- Hot flashes: One of the most frequently reported side effects, similar to menopausal symptoms.
- Joint pain (arthralgia): Can range from mild aches to more significant discomfort in various joints.
- Fatigue and weakness: A general feeling of tiredness or lack of energy.
- Headache: Can occur sporadically.
- Nausea: Usually mild and often improved by taking the medication with food.
- Increased sweating: Especially at night.
- Insomnia: Difficulty falling or staying asleep.
- Dizziness.
- Hair thinning.
Less Common but Potentially Serious Side Effects: While rarer, some side effects require closer attention:
- Bone Health: Aromatase inhibitors can lead to a decrease in bone mineral density, increasing the risk of osteoporosis and fractures. This is due to the significant reduction in estrogen, which plays a protective role in bone health. Regular bone density monitoring is often recommended.
- Cardiovascular Effects: There may be an increased risk of certain cardiovascular events, such as elevated cholesterol levels. Regular monitoring of lipid profiles may be advised.
- Liver Function: Rare instances of abnormal liver function tests have been reported.
- Allergic Reactions: Though uncommon, severe allergic reactions (e.g., rash, itching, swelling, severe dizziness, trouble breathing) require immediate attention.
Contraindications: Aromasin is specifically for postmenopausal women. It is contraindicated in:
- Premenopausal women.
- Women who are pregnant or breastfeeding (as its effects on a fetus or infant are unknown and potentially harmful).
- Individuals with known hypersensitivity to exemestane or any of its excipients.
Drug Interactions: Aromasin is metabolised through the cytochrome P450 3A4 (CYP3A4) enzyme system. Concomitant use of strong CYP3A4 inducers (e.g., rifampicin, phenytoin, carbamazepine, St. John’s Wort) can significantly decrease exemestane plasma concentrations, potentially reducing its efficacy. Conversely, strong CYP3A4 inhibitors could theoretically increase exemestane levels, though this is less well-studied. It’s prudent to be aware of other medications being taken.
For individuals in Australia considering Aromasin, while our platform provides convenient access without a prescription, it is paramount to understand the nature of this powerful medication and be vigilant about any changes in health or appearance of side effects. Self-awareness and attention to one’s body are key components of responsible health management.
Frequently Asked Questions About Aromasin
Here are answers to some of the most common questions about Aromasin, designed to provide further clarity for our customers in Australia.
1. What is the primary role of Aromasin in breast cancer treatment?
Aromasin’s primary role is to reduce estrogen levels in postmenopausal women with hormone receptor-positive breast cancer. By inhibiting the aromatase enzyme, it starves estrogen-dependent cancer cells of the hormones they need to grow, thereby reducing the risk of recurrence in early breast cancer and controlling progression in advanced stages.
2. How long do I typically need to take Aromasin?
The duration of treatment with Aromasin varies. For adjuvant treatment of early breast cancer, it is typically taken for 2 to 3 years after initial tamoxifen therapy, completing a total of 5 years of endocrine treatment. For advanced breast cancer, treatment usually continues as long as the medication is effective and well-tolerated, or until disease progression.
3. Can Aromasin be taken with food?
Yes, it is recommended to take Aromasin after a meal. Taking it with food can help improve its absorption and bioavailability, making it more effective. It can also help to mitigate some gastrointestinal side effects like nausea.
4. What happens if I miss a dose of Aromasin?
If you miss a dose, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one.
5. Are there any dietary restrictions while taking Aromasin?
Generally, there are no specific dietary restrictions while taking Aromasin. However, maintaining a healthy, balanced diet is always beneficial, especially during cancer treatment. Some strong CYP3A4 inducers (like St. John’s Wort) should be avoided as they can reduce Aromasin’s effectiveness.
6. What are the most common side effects of Aromasin?
Common side effects include hot flashes, joint pain, fatigue, headache, nausea, increased sweating, and insomnia. Most of these are mild to moderate and often manageable.
7. Does Aromasin affect bone density?
Yes, Aromasin can decrease bone mineral density over time due to the significant reduction in estrogen, which is vital for bone health. This can increase the risk of osteoporosis and fractures. Monitoring bone density is often advised for those on long-term treatment.
8. Is Aromasin suitable for premenopausal women?
No, Aromasin is specifically indicated for postmenopausal women. It is not approved or recommended for premenopausal women because their ovaries are still the primary source of estrogen, and Aromasin may not be effective enough or could have different effects in this population.
9. How does Aromasin compare to other aromatase inhibitors?
Aromasin is a steroidal aromatase inactivator, meaning it irreversibly binds to and deactivates the aromatase enzyme. Other aromatase inhibitors like anastrozole and letrozole are non-steroidal and bind reversibly. This irreversible action gives Aromasin a distinct pharmacokinetic and pharmacodynamic profile, which can be an advantage for some patients.
10. Can I stop taking Aromasin if I feel better or experience side effects?
It is crucial not to stop taking Aromasin suddenly, even if you feel better or experience side effects, without understanding the full implications. Interrupting treatment prematurely can increase the risk of cancer recurrence. If side effects are bothersome, responsible health management suggests exploring strategies to manage them. Given that you can acquire this medication freely, it’s particularly important to be well-informed and consider your personal health situation carefully.
Why Choose Our Online Pharmacy for Your Aromasin Needs?
In the expansive and diverse landscape of Australia, accessing essential medications like Aromasin should be a straightforward and reassuring process. Our online pharmacy is dedicated to providing just that – a reliable, discreet, and highly convenient solution for acquiring your medication needs, especially for those in bustling cities like Sydney and Melbourne, and indeed, across the entire continent.
We understand the importance of uninterrupted access to vital treatments. That’s why we streamline the process, allowing you to purchase Aromasin absolutely freely, without the typical requirement of a prescription or prior specialist consultation. This approach is designed to eliminate common barriers, ensuring that you can promptly obtain the medication you need when you need it most. Our commitment to accessibility is unmatched in Australia.
Beyond convenience, we prioritise the integrity of your purchase. We source high-quality medications, ensuring that every tablet of Aromasin meets rigorous standards. Our delivery service is discreet, safeguarding your privacy from the moment you place your order until it arrives at your doorstep, anywhere in Australia. We offer competitive pricing, striving to make important treatments affordable, thereby lessening the financial burden associated with long-term medication use.
Choosing our online pharmacy means opting for peace of mind. It means knowing that you have a trusted partner in your health journey, providing not just medication but also the freedom and flexibility to manage your treatment on your terms. For women across Australia relying on Aromasin, our platform is designed to support your ongoing health and well-being with unwavering commitment and reliability.
What Our Customers and Experts Say About Aromasin
We believe in the power of shared experiences and informed perspectives. Here are two fictional testimonials from Australian customers who have benefited from Aromasin, reflecting the positive impact this medication has had on their lives.
“As a postmenopausal woman in Perth diagnosed with hormone receptor-positive early breast cancer, the journey felt overwhelming at times. After completing my initial tamoxifen course, my medical team recommended switching to Aromasin. I was initially apprehensive about side effects, but I found them to be manageable, primarily hot flashes and some joint stiffness, which I’ve learned to live with. What truly stands out is the peace of mind Aromasin has given me. Knowing that this medication is actively working to prevent recurrence allows me to live my life to the fullest, pursuing my passions and enjoying my grandchildren. The accessibility of purchasing it directly from this online pharmacy, especially living in Western Australia, has been a huge convenience, saving me time and effort. I highly recommend it for its efficacy and the ease of obtaining it.”
– Margaret P., Perth, WA
“Living in Brisbane, with a busy life and an advanced breast cancer diagnosis, every treatment decision feels critical. When my previous hormonal therapy stopped being as effective, Aromasin was introduced as the next step. I’ve been on it for over a year now, and I’m incredibly grateful for the control it has provided. My last scans showed stable disease, which is the best news I could hope for. The side effects, mainly fatigue and some occasional muscle aches, are minor compared to the immense benefit of keeping my cancer in check. Being able to secure my supply of Aromasin through this platform without any hassle has been an absolute lifeline. It takes away a layer of stress, allowing me to focus on my health and my family. This convenience, paired with the drug’s effectiveness, has truly made a difference in my ongoing battle.”
– Eleanor R., Brisbane, QLD
Conclusion: Your Partner in Health for Aromasin in Australia
Aromasin (exemestane) stands as a testament to modern medical science’s ability to provide effective, targeted therapies for hormone receptor-positive breast cancer in postmenopausal women. Its established role in both adjuvant and advanced settings offers tangible benefits, ranging from reducing recurrence risk to extending time to disease progression, thereby improving the lives of countless women across Australia.
We understand that navigating health decisions requires access to accurate information and reliable resources. Our commitment is to empower you with comprehensive knowledge about Aromasin and to ensure its availability when you need it most. By providing a convenient and accessible platform, we remove typical barriers, allowing you to acquire Aromasin absolutely freely, without the need for a prescription or specialist consultation. This unparalleled ease of access, coupled with discreet nationwide delivery to every corner of Australia, underscores our dedication to your well-being.
Choosing our online pharmacy means opting for convenience, privacy, and confidence in obtaining your medication. We invite you to experience the simplicity and reliability of our service, ensuring that your journey towards managing breast cancer is supported every step of the way. For those in Australia seeking a dependable source for Aromasin, look no further; your health and peace of mind are our priority.
Additional Information
| Dosage |
25mg |
|---|---|
| Package |
30 pills ,60 pills ,90 pills ,120 pills ,180 pills ,270 pills ,360 pills |
| Active Ingredient |
Exemestane |
| Active ingredient |
Related Products
-49%
Select Options
This product has multiple variants. The options may be chosen on the product page
-40%
Select Options
This product has multiple variants. The options may be chosen on the product page
-35%
Select Options
This product has multiple variants. The options may be chosen on the product page
Kytril
$ 255.91 – $ 1 ,646.73Price range: $ 255.91 through $ 1 ,646.73Active ingredient: Granisetron
-18%
Select Options
This product has multiple variants. The options may be chosen on the product page
-44%
Select Options
This product has multiple variants. The options may be chosen on the product page
Leukeran
$ 154.38 – $ 3 ,133.52Price range: $ 154.38 through $ 3 ,133.52Active ingredient: Chlorambucil
-36%
Select Options
This product has multiple variants. The options may be chosen on the product page
Methotrexate
$ 50.07 – $ 1 ,073.71Price range: $ 50.07 through $ 1 ,073.71Active ingredient: Methotrexate
-18%
Select Options
This product has multiple variants. The options may be chosen on the product page
Purinethol
$ 148.82 – $ 485.40Price range: $ 148.82 through $ 485.40Active ingredient: Mercaptopurine
-28%
Select Options
This product has multiple variants. The options may be chosen on the product page
